Literature DB >> 19759611

Genomics: Hepatitis C virus gets personal.

Shawn P Iadonato, Michael G Katze.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19759611     DOI： 10.1038/461357a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

1.  IL-28, IL-29 and their class II cytokine receptor IL-28R.

Authors:  Paul Sheppard; Wayne Kindsvogel; Wenfeng Xu; Katherine Henderson; Stacy Schlutsmeyer; Theodore E Whitmore; Rolf Kuestner; Ursula Garrigues; Carl Birks; Jenny Roraback; Craig Ostrander; Dennis Dong; Jinu Shin; Scott Presnell; Brian Fox; Betty Haldeman; Emily Cooper; David Taft; Teresa Gilbert; Francis J Grant; Monica Tackett; William Krivan; Gary McKnight; Chris Clegg; Don Foster; Kevin M Klucher
Journal:  Nat Immunol       Date:  2002-12-02       Impact factor: 25.606

2.  A haplotype map of the human genome.

Authors: 
Journal:  Nature       Date:  2005-10-27       Impact factor: 49.962

3.  Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.

Authors:  Gerd Fätkenheuer; Anton L Pozniak; Margaret A Johnson; Andreas Plettenberg; Schlomo Staszewski; Andy I M Hoepelman; Michael S Saag; Frank D Goebel; Jürgen K Rockstroh; Bruce J Dezube; Tim M Jenkins; Christine Medhurst; John F Sullivan; Caroline Ridgway; Samantha Abel; Ian T James; Mike Youle; Elna van der Ryst
Journal:  Nat Med       Date:  2005-10-05       Impact factor: 53.440

4.  Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection.

Authors:  John G McHutchison; Eric J Lawitz; Mitchell L Shiffman; Andrew J Muir; Greg W Galler; Jonathan McCone; Lisa M Nyberg; William M Lee; Reem H Ghalib; Eugene R Schiff; Joseph S Galati; Bruce R Bacon; Mitchell N Davis; Pabak Mukhopadhyay; Kenneth Koury; Stephanie Noviello; Lisa D Pedicone; Clifford A Brass; Janice K Albrecht; Mark S Sulkowski
Journal:  N Engl J Med       Date:  2009-07-22       Impact factor: 91.245

5.  Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.

Authors:  Hari S Conjeevaram; Michael W Fried; Lennox J Jeffers; Norah A Terrault; Thelma E Wiley-Lucas; Nezam Afdhal; Robert S Brown; Steven H Belle; Jay H Hoofnagle; David E Kleiner; Charles D Howell
Journal:  Gastroenterology       Date:  2006-08       Impact factor: 22.682

6.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

7.  Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.

Authors:  Dongliang Ge; Jacques Fellay; Alexander J Thompson; Jason S Simon; Kevin V Shianna; Thomas J Urban; Erin L Heinzen; Ping Qiu; Arthur H Bertelsen; Andrew J Muir; Mark Sulkowski; John G McHutchison; David B Goldstein
Journal:  Nature       Date:  2009-08-16       Impact factor: 49.962

8.  IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.

Authors:  Vijayaprakash Suppiah; Max Moldovan; Golo Ahlenstiel; Thomas Berg; Martin Weltman; Maria Lorena Abate; Margaret Bassendine; Ulrich Spengler; Gregory J Dore; Elizabeth Powell; Stephen Riordan; David Sheridan; Antonina Smedile; Vincenzo Fragomeli; Tobias Müller; Melanie Bahlo; Graeme J Stewart; David R Booth; Jacob George
Journal:  Nat Genet       Date:  2009-09-13       Impact factor: 38.330
  8 in total
  11 in total

Review 1.  Genome-wide association studies in pharmacogenomics.

Authors:  Ann K Daly
Journal:  Nat Rev Genet       Date:  2010-04       Impact factor: 53.242

Review 2.  Personalized medicine: Genetic risk prediction of drug response.

Authors:  Ge Zhang; Daniel W Nebert
Journal:  Pharmacol Ther       Date:  2017-02-14       Impact factor: 12.310

3.  The rs8099917 polymorphism, when determined by a suitable genotyping method, is a better predictor for response to pegylated alpha interferon/ribavirin therapy in Japanese patients than other single nucleotide polymorphisms associated with interleukin-28B.

Authors:  Kiyoaki Ito; Katsuya Higami; Naohiko Masaki; Masaya Sugiyama; Motokazu Mukaide; Hiroaki Saito; Yoshihiko Aoki; Yo Sato; Masatoshi Imamura; Kazumoto Murata; Hideyuki Nomura; Shuhei Hige; Hiroshi Adachi; Keisuke Hino; Hiroshi Yatsuhashi; Etsuro Orito; Satomi Kani; Yasuhito Tanaka; Masashi Mizokami
Journal:  J Clin Microbiol       Date:  2011-03-09       Impact factor: 5.948

4.  Extended therapy with pegylated interferon and weight-based ribavirin for HCV-HIV coinfected patients.

Authors:  Raymond T Chung; Triin Umbleja; Jennifer Y Chen; Janet W Andersen; Adeel A Butt; Kenneth E Sherman
Journal:  HIV Clin Trials       Date:  2012 Mar-Apr

5.  Interleukin 28B Polymorphisms and Hepatitis C-Translating the Association into Clinical Decision Making.

Authors:  Col Pankaj Puri
Journal:  J Clin Exp Hepatol       Date:  2011-08-26

6.  Factors associated with early virological response to peginterferon-α-2a/ribavirin in chronic hepatitis C.

Authors:  Javier García-Samaniego; Miriam Romero; Rafael Granados; Remedios Alemán; Miguel Jorge Juan; Dolores Suárez; Ramón Pérez; Gregorio Castellano; Carlos González-Portela
Journal:  World J Gastroenterol       Date:  2013-03-28       Impact factor: 5.742

7.  Novel biosensor-based microarray assay for detecting rs8099917 and rs12979860 genotypes.

Authors:  Pei-Yuan Li; Xiao-Jun Zhou; Lan Yao; Xin-Hua Fang; Jiang-Nan Ren; Jia-Wu Song
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

8.  The impact of host factors on management of hepatitis C virus.

Authors:  Mahmoud Aboelneen Khattab; Mohammed Eslam
Journal:  Hepat Mon       Date:  2012-04-30       Impact factor: 0.660

9.  IL28B SNP rs12979860 is a critical predictor for on-treatment and sustained virologic response in patients with hepatitis C virus genotype-1 infection.

Authors:  Chun-Yen Lin; Ji-Yih Chen; Tsung-Nan Lin; Wen-Juei Jeng; Chien-Hao Huang; Chang-Wen Huang; Su-Wei Chang; I-Shyan Sheen
Journal:  PLoS One       Date:  2011-03-30       Impact factor: 3.240

Review 10.  Omics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric Disorders.

Authors:  Sumit Sethi; Elisa Brietzke
Journal:  Int J Neuropsychopharmacol       Date:  2015-10-09       Impact factor: 5.176
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.